BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38693097)

  • 1. Severe neonatal thrombocytopenia due to anti-HPA-4b alloantibodies: Third report described in a Caucasian mother.
    Petermann R; Bianchi F; Saib L; Ferré N; Francelle N; Oudin O; Chenet C; Mammasse Y; Jallu V; Chaussade A; Cornu A; Dubray L; Mailloux A
    Transfusion; 2024 Jun; 64(6):1167-1170. PubMed ID: 38693097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cab4b, the first human platelet antigen carried by glycoprotein IX discovered in a context of severe neonatal thrombocytopenia.
    Jallu V; Beranger T; Bianchi F; Casale C; Chenet C; Ferre N; Philippe S; Quesne J; Martageix C; Petermann R
    J Thromb Haemost; 2017 Aug; 15(8):1646-1654. PubMed ID: 28561420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first reported case of neonatal alloimmune thrombocytopenia due to low-frequency human platelet antigen-6b antibodies in the United Kingdom.
    Hopkins M; Brookes J; Watson D; Wroe E; Guthrie P; Horler J; Anayattil K; Calvert A; Poles A
    Transfusion; 2021 Sep; 61(9):2788-2794. PubMed ID: 34156106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
    Kjeldsen-Kragh J; Bengtsson J
    Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia.
    de Vos TW; Porcelijn L; Hofstede-van Egmond S; Pajkrt E; Oepkes D; Lopriore E; van der Schoot CE; Winkelhorst D; de Haas M
    Br J Haematol; 2021 Nov; 195(4):595-603. PubMed ID: 34402048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HPA-9bw (Maxa) fetomaternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy and report on eight families.
    Kaplan C; Porcelijn L; Vanlieferinghen P; Julien E; Bianchi F; Martageix C; Bertrand G; Jallu V
    Transfusion; 2005 Nov; 45(11):1799-803. PubMed ID: 16271107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of neonatal alloimmune thrombocytopenia in the presence of both anti-HPA-4b and anti-HPA-5b antibody: clinical and serological analysis of the subsequent pregnancy.
    Kiyokawa T; Koh Y; Mimura K; Nakayama K; Hosokawa M; Sakuragi M; Morikawa T; Nakao M; Aochi H; Fukumori Y; Kanagawa T; Nagamine K; Kimura T; Tomiyama Y
    Int J Hematol; 2014 Oct; 100(4):398-401. PubMed ID: 24972694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FNAIT pathogenesis determined by serial analysis of three subsequent pregnancies of a woman with severe fetal and neonatal alloimmune thrombocytopenia (FNAIT) with anti-HPA-4b and anti-HPA-5b alloantibodies in the first sibling.
    Kiyokawa T; Mimura K; Nagamine K; Nakayama K; Horiuchi M; Morikawa T; Hosokawa M; Nakao M; Endo M; Kimura T; Kato H; Tomiyama Y; Kashiwagi H
    Int J Hematol; 2023 Jul; 118(1):146-150. PubMed ID: 36797397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.
    Kjaer M; Bertrand G; Bakchoul T; Massey E; Baker JM; Lieberman L; Tanael S; Greinacher A; Murphy MF; Arnold DM; Baidya S; Bussel J; Hume H; Kaplan C; Oepkes D; Ryan G; Savoia H; Shehata N; Kjeldsen-Kragh J;
    Vox Sang; 2019 Jan; 114(1):79-94. PubMed ID: 30565711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HPA-4b (anti-Yuk(a)) neonatal alloimmune thrombocytopenia: first report in a Caucasian family.
    Morel-Kopp MC; Blanchard B; Kiefel V; Joly C; Mueller-Eckhardt C; Kaplan C
    Transfus Med; 1992 Dec; 2(4):273-6. PubMed ID: 1339581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPA-5 typing discrepancy reveals an Ile503Leu substitution in platelet GPIa (α2 integrin).
    Bertrand G; Jallu V; Beranger T; Bianchi F; Casale C; Dufour V; Chenet C; Quesne J; Martageix C; Kaplan C
    Vox Sang; 2013 Jul; 105(1):73-6. PubMed ID: 23368983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe fetomaternal alloimmune thrombocytopenia due to anti-human platelet antigen (HPA)-1a in a mother with a rare and silenced ITGB3*0101 (GPIIIa) allele.
    Smith GA; Rankin A; Riddle C; Cheetham-Wilkinson C; Ranasinghe E; Ouwehand WH; Watkins NA
    Vox Sang; 2007 Nov; 93(4):325-30. PubMed ID: 18070277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe HPA-15b related neonatal alloimmune thrombocytopenia.
    Moncharmont P; Courvoisier S; Pagnier A; Cotta L; Debillon T; Rigal D
    Acta Paediatr; 2007 Nov; 96(11):1701-3. PubMed ID: 17850392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe neonatal alloimmune thrombocytopenia due to anti-HPA-3a.
    Boehlen F; Kaplan C; de Moerloose P
    Vox Sang; 1998; 74(3):201-4. PubMed ID: 9595650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal alloimmune thrombocytopenia caused by an antibody specific for a newly identified allele of human platelet antigen-7.
    Koh Y; Taniue A; Ishii H; Matsuyama N; Amakishi E; Hayashi T; Furuta RA; Fukumori Y; Hirayama F; Yoshimura K; Nagamine T; Tamai S; Nakano S
    Transfusion; 2010 Jun; 50(6):1276-84. PubMed ID: 20070614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of HPA-3 alloantibodies: consequences for the diagnosis of alloimmune thrombocytopenic syndromes.
    Socher I; Zwingel C; Santoso S; Kroll H
    Transfusion; 2008 Mar; 48(3):463-72. PubMed ID: 18067506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-avidity HPA-1a alloantibodies in severe neonatal alloimmune thrombocytopenia are detectable with surface plasmon resonance technology.
    Socher I; Andrei-Selmer C; Bein G; Kroll H; Santoso S
    Transfusion; 2009 May; 49(5):943-52. PubMed ID: 19175553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIP (HPA-screening in pregnancy) study: protocol of a nationwide, prospective and observational study to assess incidence and natural history of fetal/neonatal alloimmune thrombocytopenia and identifying pregnancies at risk.
    Winkelhorst D; de Vos TW; Kamphuis MM; Porcelijn L; Lopriore E; Oepkes D; van der Schoot CE; de Haas M
    BMJ Open; 2020 Jul; 10(7):e034071. PubMed ID: 32690731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked thrombocytopenia in a neonate is associated with anti-HPA-5b, anti-HLA-A31, and anti-HLA-B55 antibodies.
    Okubo M; Nishida E; Watanabe A; Nishizaki N; Obinata K; Azuma F; Matsuhashi M; Watanabe-Okochi N; Tsuno NH; Miyake K; Yamaguchi M; Yoshida K; Ohsaka A
    Pediatr Blood Cancer; 2019 Mar; 66(3):e27555. PubMed ID: 30488611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The implementation of surface plasmon resonance technique in monitoring pregnancies with expected fetal and neonatal alloimmune thrombocytopenia.
    Bakchoul T; Bertrand G; Krautwurst A; Kroll H; Bein G; Sachs UJ; Santoso S; Kaplan C
    Transfusion; 2013 Sep; 53(9):2078-85. PubMed ID: 23278334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.